Chronolife Revenue and Competitors
Estimated Revenue & Valuation
- Chronolife's estimated annual revenue is currently $3.8M per year.
- Chronolife's estimated revenue per employee is $251,000
Employee Data
- Chronolife has 15 Employees.
- Chronolife grew their employee count by -29% last year.
Chronolife's People
| Name | Title | Email/Phone | 
|---|
Chronolife Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation | 
|---|---|---|---|---|---|
| #1 | $13.6M | 54 | 8% | N/A | N/A | 
| #2 | $17.1M | 68 | 8% | N/A | N/A | 
| #3 | $104.2M | 415 | 5% | N/A | N/A | 
| #4 | $79.8M | 318 | 21% | N/A | N/A | 
| #5 | $9.3M | 37 | -14% | N/A | N/A | 
| #6 | $153.1M | 610 | 21% | N/A | N/A | 
| #7 | $6.5M | 26 | -40% | N/A | N/A | 
| #8 | $19.1M | 76 | -11% | N/A | N/A | 
| #9 | $175.3M | 499 | -11% | €83.1M | N/A | 
| #10 | $3.8M | 15 | -29% | N/A | N/A | 
What Is Chronolife?
Chronolife is bringing a new era in the field of diagnostics that accompanies doctors & clinicians in faster & more efficient decision making Groundbreaking AI technology The power of Artificial intelligence & Neuromorphic engineering are harnessed into a disruptive algorithm able to single out & characterize even sparse clinical events. Â Easy & integrated solutions Through smart & connected devices where all relevant medical data is at the fingertips of patients & healthcare professionals.
keywords:N/AN/A
Total Funding
15
Number of Employees
$3.8M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chronolife News
April 2022/PRNewswire/ -- Chronolife, ein Dienstleistungsunternehmen im Gesundheitswesen, gab heute den Start einer klinischen Untersuchung...
Rigshospitalet, el principal hospital de Dinamarca con sede en Copenhague, colabora con Chronolife para una investigación clínica en...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | 
|---|---|---|---|---|
| #1 | $2M | 15 | N/A | N/A | 
| #2 | $1.5M | 15 | N/A | N/A | 
| #3 | $1.9M | 15 | -12% | N/A | 
| #4 | $1.3M | 15 | -12% | N/A | 
| #5 | $1.3M | 15 | 0% | N/A | 
